Altimmune, Inc.ALTNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank14
5Y CAGR-65.3%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

5Y CAGR
-65.3%/yr
Long-term compound
Percentile
P14
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$41000.00+105.0%
2024$20000.00-95.3%
2023$426000.00+726.5%
2022$-68000.00-101.5%
2021$4.41M-46.1%
2020$8.19M+41.1%
2019$5.80M-43.8%
2018$10.33M+24792.6%
2017$41503.00-99.2%
2016$5.23M-